REFERENCES
- Remuzzi G. HUS and TTP: variable expression of a single entity. Kidney Int. 1987;32:292–308.
- Clark WF. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange. Semin Dial. 2012;25:214–219.
- Motto D. Endothelial cells and thrombotic microangiopathy. Semin Nephrol. 2012;32:208–214.
- Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347:589–600.
- Sadler JE, Moake JL, Miyata T, George JN. Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2004:407–423.
- Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16:1035–1050.
- Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and hemolytic uraemic syndrome. Lancet. 2005;365:1073–1086.
- Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361:1676–1687.
- Zuber J, Le Quintrec M, Sberro-Soussan R, Loirat C, Fremeaux-Bacchi V, Legendre C. New insights into postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol. 2011;7:23–35.
- Hirsh LF. Vasculitis, thrombotic thrombocytopenic purpura, and stroke after aneurysm surgery. Surg Neurol. 1982;17:426–428.
- Naqvi TA, Baumann MA, Chang JC. Post-operative thrombotic thrombocytopenic purpura: a review. Int J Clin Pract. 2004;58:169–172.
- Maki S, Miyata H, Uda H. Hemolytic-uremic syndrome: fatal case after operation for intussusception as complication of upper respiratory tract infection. Med J Osaka Univ. 1968;19:157–173.
- Taylor CM, Machin S, Wigmore SJ, Goodship TH. Clinical practice guidelines for the management of atypical hemolytic uraemic syndrome in the United Kingdom. Br J Hematol. 2010;148:37–47.
- Besbas N, Karpman D, Landau D, et al. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006; 70:423–431.
- Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 2001;60:831–846.
- Zakarija A, Bennett C. Drug-induced thrombotic microangiopathy. Semin Thromb Hemost. 2005;31:681–690.
- Prakash J, Vohra R, Wani IA, et al. Decreasing incidence of renal cortical necrosis in patients with acute renal failure in developing countries: a single-centre experience of 22 years from eastern India. Nephrol Dial Transplant. 2007;22:1213–1217.
- Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med. 1991;325:398–403.
- Noris M, Caprioli J, Bresin E, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010;5:1844–1859.
- Kaplan AA. Therapeutic plasma exchange: core curriculum 2008. Am J Kidney Dis. 2008;52:1180–1196.